67 related articles for article (PubMed ID: 35561840)
1. Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.
Pallavajjala A; Haley L; Stinnett V; Adams E; Pallavajjala R; Huang J; Morsberger L; Hardy M; Long P; Gocke CD; Eshleman JR; Rodriguez FJ; Zou YS
Hum Pathol; 2022 Aug; 126():63-76. PubMed ID: 35561840
[TBL] [Abstract][Full Text] [Related]
2. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
Arita H; Matsushita Y; Machida R; Yamasaki K; Hata N; Ohno M; Yamaguchi S; Sasayama T; Tanaka S; Higuchi F; Iuchi T; Saito K; Kanamori M; Matsuda KI; Miyake Y; Tamura K; Tamai S; Nakamura T; Uda T; Okita Y; Fukai J; Sakamoto D; Hattori Y; Pareira ES; Hatae R; Ishi Y; Miyakita Y; Tanaka K; Takayanagi S; Otani R; Sakaida T; Kobayashi K; Saito R; Kurozumi K; Shofuda T; Nonaka M; Suzuki H; Shibuya M; Komori T; Sasaki H; Mizoguchi M; Kishima H; Nakada M; Sonoda Y; Tominaga T; Nagane M; Nishikawa R; Kanemura Y; Kuchiba A; Narita Y; Ichimura K
Acta Neuropathol Commun; 2020 Nov; 8(1):201. PubMed ID: 33228806
[TBL] [Abstract][Full Text] [Related]
3. A custom next-generation sequencing panel for 1p/19q codeletion and mutational analysis in gliomas.
Qi P; Yao QL; Lao IW; Ren M; Bai QM; Cai X; Xue T; Wei R; Zhou XY
J Neuropathol Exp Neurol; 2024 Mar; 83(4):258-267. PubMed ID: 38408388
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis.
Figarella-Branger D; Mokhtari K; Colin C; Uro-Coste E; Jouvet A; Dehais C; Carpentier C; Villa C; Maurage CA; Eimer S; Polivka M; Vignaud JM; Laquerriere A; Sevestre H; Lechapt-Zalcman E; Quintin-Roué I; Aubriot-Lorton MH; Diebold MD; Viennet G; Adam C; Loussouarn D; Michalak S; Rigau V; Heitzmann A; Vandenbos F; Forest F; Chiforeanu D; Tortel MC; Labrousse F; Chenard MP; Nguyen AT; Varlet P; Kemeny JL; Levillain PM; Cazals-Hatem D; Richard P; Delattre JY;
Brain Pathol; 2015 Jul; 25(4):418-28. PubMed ID: 25407774
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.
Vogazianou AP; Chan R; Bäcklund LM; Pearson DM; Liu L; Langford CF; Gregory SG; Collins VP; Ichimura K
Neuro Oncol; 2010 Jul; 12(7):664-78. PubMed ID: 20164239
[TBL] [Abstract][Full Text] [Related]
6. Machine learning modeling of genome-wide copy number alteration signatures reliably predicts IDH mutational status in adult diffuse glioma.
Nuechterlein N; Shapiro LG; Holland EC; Cimino PJ
Acta Neuropathol Commun; 2021 Dec; 9(1):191. PubMed ID: 34863298
[TBL] [Abstract][Full Text] [Related]
7. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment.
Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
[TBL] [Abstract][Full Text] [Related]
8. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
Ichimura K; Pearson DM; Kocialkowski S; Bäcklund LM; Chan R; Jones DT; Collins VP
Neuro Oncol; 2009 Aug; 11(4):341-7. PubMed ID: 19435942
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtyping of tumors from patients with familial glioma.
Ruiz VY; Praska CE; Armstrong G; Kollmeyer TM; Yamada S; Decker PA; Kosel ML; Eckel-Passow JE; Lachance DH; Bainbridge MN; Melin BS; Bondy ML; Jenkins RB;
Neuro Oncol; 2018 May; 20(6):810-817. PubMed ID: 29040662
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of MRI in Detecting 1p/19q Co-deletion Status of Gliomas: A Single-Center Retrospective Study.
Naeem A; Aziz N; Nasir M; Rangwala HS; Fatima H; Mubarak F
Cureus; 2024 Jan; 16(1):e51863. PubMed ID: 38327950
[TBL] [Abstract][Full Text] [Related]
11. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.
Sasaki H; Kitamura Y; Toda M; Hirose Y; Yoshida K
Brain Tumor Pathol; 2024 Apr; 41(2):43-49. PubMed ID: 38564040
[TBL] [Abstract][Full Text] [Related]
12. Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing.
Li C; Liu Z; Zhang X; Wang H; Friedman GK; Ding Q; Zhao X; Li H; Kim K; Yu X; Burt Nabors L; Han X; Zhao R
Neurooncol Adv; 2022; 4(1):vdac131. PubMed ID: 36225650
[TBL] [Abstract][Full Text] [Related]
13. Predictors and early survival outcomes of maximal resection in WHO grade II 1p/19q-codeleted oligodendrogliomas.
Harary M; Kavouridis VK; Torre M; Zaidi HA; Chukwueke UN; Reardon DA; Smith TR; Iorgulescu JB
Neuro Oncol; 2020 Mar; 22(3):369-380. PubMed ID: 31538193
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples.
Solomon JP; Munoz-Zuluaga C; Slocum C; Dillard A; Cong L; Wang J; Lindeman N; Kluk M; Liechty B; Pisapia D; Rennert H; Velu PD
Diagn Pathol; 2024 May; 19(1):70. PubMed ID: 38796421
[TBL] [Abstract][Full Text] [Related]
15. Clinical Evaluation of IDH Mutation Status in Formalin-Fixed Paraffin-Embedded Tissue in Gliomas.
Nelson EJ; Gubbiotti MA; Carlin AM; Nasrallah MP; Van Deerlin VM; Herlihy SE
Mol Diagn Ther; 2023 May; 27(3):371-381. PubMed ID: 36690887
[TBL] [Abstract][Full Text] [Related]
16. BRAF V600E mutant oligodendroglioma-like tumors with chromosomal instability in adolescents and young adults.
Fukuoka K; Mamatjan Y; Ryall S; Komosa M; Bennett J; Zapotocky M; Keith J; Myrehaug S; Hazrati LN; Aldape K; Laperriere N; Bouffet E; Tabori U; Hawkins C
Brain Pathol; 2020 May; 30(3):515-523. PubMed ID: 31630459
[TBL] [Abstract][Full Text] [Related]
17. Rapid intraoperative multi-molecular diagnosis of glioma with ultrasound radio frequency signals and deep learning.
Xie X; Shen C; Zhang X; Wu G; Yang B; Qi Z; Tang Q; Wang Y; Ding H; Shi Z; Yu J
EBioMedicine; 2023 Dec; 98():104899. PubMed ID: 38041959
[TBL] [Abstract][Full Text] [Related]
18. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.
Nikiforova MN; Wald AI; Melan MA; Roy S; Zhong S; Hamilton RL; Lieberman FS; Drappatz J; Amankulor NM; Pollack IF; Nikiforov YE; Horbinski C
Neuro Oncol; 2016 Mar; 18(3):379-87. PubMed ID: 26681766
[TBL] [Abstract][Full Text] [Related]
19. Moving toward molecular classification of diffuse gliomas in adults.
Theeler BJ; Yung WK; Fuller GN; De Groot JF
Neurology; 2012 Oct; 79(18):1917-26. PubMed ID: 23109653
[TBL] [Abstract][Full Text] [Related]
20. Genetic profiling of rat gliomas and cardiac schwannomas from life-time radiofrequency radiation exposure study using a targeted next-generation sequencing gene panel.
Brooks AM; Vornoli A; Kovi RC; Ton TVT; Xu M; Mashal A; Tibaldi E; Gnudi F; Li JL; Sills RC; Bucher JR; Mandrioli D; Belpoggi F; Pandiri AR
PLoS One; 2024; 19(1):e0296699. PubMed ID: 38232086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
